Director Peter van der Velden resigns from Edesa Biotech board effective Feb 28, 2022

Edesa Biotech, Inc.

Peter van der Velden resigned as director effective Feb 28, 2022; he had served since 2015.
Departure is not due to any disagreement with the company's operations, policies, or procedures.
His firm remains an investor in Edesa Biotech.
Nominating and governance committee (chaired by van der Velden) engaged a search firm to evaluate board composition and diversity.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter van der Velden

Director

EDSA · Edesa Biotech, Inc.

Effective: 2022-02-28
Filed: March 2, 2022, 6:59 PM ET

On February 28, 2022, Peter van der Velden notified the Board of Directors (the “Board”) of Edesa Biotech, Inc. (the “Company”) of his decision to resign from the Board and its committees, effective as of February 28, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter van der Velden resigned as Director at Edesa Biotech, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 28, 2022, Peter van der Velden notified the Board of Directors (the “Board”) of Edesa Biotech, Inc. (the “Company”) of his decision to resign from the Board and its committees, effective as of February 28, 2022.

View on SEC.gov

Edesa Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-22-002417

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.